+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

I

Actively Recruiting

Healthy Volunteer

Researchers are studying how different partially hydrolyzed, whey-based infant formulas affect growth and digestive comfort in healthy full-term infants. This is a randomized, controlled trial comparing two experimental formulas made with hydrolyzed protein to a control formula containing intact protein. The study aims to understand how these formulas influence infant growth over the first four months and their gastrointestinal tolerance. Participants will receive one of three infant formulas a control formula with intact protein, Experimental Formula 1 with hydrolyzed protein, or Experimental Formula 2 also with hydrolyzed protein but produced using a different milk protein base. These formulas differ slightly in protein content and processing. The study follows infants from enrollment until they reach 4 months of age to assess growth differences and equivalence, while also monitoring for tolerance. During the study, researchers will monitor participants growth through measurements like weight, length, and head circumference at various ages up to 6 months. They will also assess gastrointestinal tolerance, stool patterns, allergy symptoms, and dietary intake through scheduled visits. The primary outcomes focus on growth during the first 4 months. This trial includes regular assessments to track infants health, development, and any allergic or digestive symptoms during their first year.

Age: 0Days - 28DaysAll GendersPhase Not Applicable
5 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating growth, tolerance, and functional biomarkers in healthy infants aged 14 to 28 days receiving dietary supplements over an 8-week period. This double-blind, randomized, placebo-controlled nutritional study includes approximately 327 healthy term infants of all feeding types. The primary goal is to compare weight gain velocity among infants given single probiotic, multi-probiotic, or placebo supplements, with secondary outcomes exploring gastrointestinal health, microbiome composition, and safety. Participants are randomly assigned to one of three groups receiving either a single probiotic supplement, a multi-probiotic supplement, or a placebo, all administered once daily in powdered form. The intervention lasts for 8 weeks followed by a 4-week follow-up, totaling about 3 months of participation. The study monitors infants from baseline until 2.5 months of age to assess growth and tolerance. During the study, infants have scheduled assessments at baseline, 1.5 months, and 2.5 months, which include measurements of weight, length, head circumference, and gastrointestinal symptoms through questionnaires and diaries. Stool samples are collected to evaluate microbiome and metabolic markers, and safety is monitored by physical exams, vital signs, and adverse event reporting throughout the study and follow-up period.

Age: 14Days - 28DaysAll GendersPhase Not Applicable
2 locations